Path-39. Ai-Based Identification Of Glioma Idh Mutational Status From H&E-Stained Whole Slide Images

Shubham Innani,Bhakti Baheti,MacLean P Nasrallah,W Robert Bell,Spyridon Bakas

DOI: https://doi.org/10.1093/neuonc/noae165.0738

2024-11-29

Neuro-Oncology

Abstract:INTRODUCTIONIsocitrate-dehydrogenase ( IDH ) mutational status is diagnostically critical in adult gliomas, with prognostic and therapeutic implications. IDH status cannot be determined by sole histologic assessment and requires molecular testing. We hypothesize that AI-based analysis can accurately predict IDH mutational status in glioma, by retrieving sub-visual cues in H&E-stained digitized tissue sections. MATERIALS AND METHODSA retrospective discovery cohort of 1,534 cases (756/778 IDH -wildtype/ IDH -mutant, including all available grades) from the TCGA-LGG/TCGA-GBM collections was used for model development with 10-fold cross-validation (CV). A replication cohort of 114 cases (82/32 IDH -wildtype/ IDH -mutant) from the University of Pennsylvania Health System (UPHS) was used for independent hold-out evaluation. Each 20X magnification whole slide image (WSI) underwent comprehensive curation for elimination of artifactual content, followed by partitioning into 256x256 patches, and feature extraction using pre-trained i) ImageNet weights (baseline), and ii) self-supervised vision transformer (ViT). A weakly-supervised attention-based multiple-instance-learning framework distinguished cases as IDH -wildtype or IDH -mutant, while generating visually interpretable attention heatmaps. RESULTSEvaluation on discovery and replication cohorts with the ViT yield accuracy of 90.84% (AUC Discovery =97.16%) and 93.94% (AUC Replication =97.36%), respectively, with high sensitivity (i.e., high confidence in correctly predicting IDH -wildtype glioma). Comparison of the ViT with the baseline model on the replication cohort indicates the ViT superiority by improvements of 8% and 9.5% in accuracy and AUC, respectively. Histologic assessment of heatmaps indicates IDH -wildtype tumors exhibiting distinct regions of significant pleomorphism and microvascular proliferation, while IDH -mutant tumors exhibit dense nodular cell concentrations, microcystic architecture, and gemistocytic cells. CONCLUSIONOur accurate H&E-based computational determination of glioma IDH status, with interpretations aligned with human-identifiable features, can contribute to obviating the need for molecular analyses and enable expedited diagnosis even in community healthcare settings. This study robustly identifies morpho- IDH correlates and could enable expedited patient prognostic stratification.

oncology,clinical neurology